HCW Biologics Inc (HCWB)

Currency in USD
4.320
+0.020(+0.47%)
Real-time Data·

HCWB Financial Summary

Key Ratios

P/E Ratio-0.17
Price/Book-0.54
Debt / Equity-162.81%
Return on Equity-27,725.96%
Dividend Yield0.00%
EBITDA-28.30M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 35.000
(+710.19% Upside)

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
5.10K / --
EPS Revisions
Last 90 days

FAQ

What were HCW Biologics's earnings for the latest quarter?

The HCW Biologics EPS (TTM) is -24.35. HCW Biologics reported sales of 0.01, net income of -2.20, and EPS of -0.05 for the latest quarter.

What was HCW Biologics's net income for the latest quarter?

HCW Biologics's net income for the latest quarter was -2.20.

How did HCW Biologics's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.39 in the previous quarter to 0.01 in the latest quarter, and net income moved from -3.37 to -2.20 compared to the previous quarter.

What is HCW Biologics's net profit margin on a TTM basis?

HCW Biologics's trailing twelve months (TTM) net profit margin is -1,169.70%.

How does HCW Biologics's debt to equity ratio compare to industry standards?

HCW Biologics's total debt-to-equity ratio is -162.81%.

What is HCW Biologics's return on investment on a TTM basis?

HCW Biologics's trailing twelve months (TTM) return on investment (ROI) is -27,725.96%.

Did HCW Biologics gain or lose cash last quarter?

In the latest quarter, HCW Biologics's net change in cash was -3.57 million.

What were HCW Biologics's total assets and liabilities in the latest quarter?

As of the latest quarter, HCW Biologics reported total assets of 26.29 million and total liabilities of 27.14 million.

How has HCW Biologics's total revenue grown this year?

HCW Biologics's total revenue was 0.39 in the previous quarter and 0.01 in the latest quarter.

What is HCW Biologics's gross margin on a TTM basis?

HCW Biologics's trailing twelve months (TTM) gross margin is 23.92%.

What was HCW Biologics's revenue per share for the latest quarter?

HCW Biologics's revenue per share for the latest quarter was 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.